Opportunity Radar

← Back to search

Grant

Reissue of RFA-FD-23-001- Clinical Studies of Orphan Products Addressing Unmet Needs of Rare Diseases (R01 Clinical Trials Required)

View on Grants.gov ↗ Sign in to save

Type
Grant
Notice type
G
Agency
Food and Drug Administration
Sub-agency
HHS-FDA
Solicitation #
RFA-FD-25-020
Posted
Jul 11, 2025
Response due
May 16, 2028
Archive date
Jun 15, 2028
CFDA / Assistance listing
93.103
Award floor
$0
Award ceiling
$900,000
Contact
Patrick.Johnson@fda.hhs.gov
Source
Grants.gov

Description

The purpose of this Notice of Funding Opportunity (NOFO) is to fund clinical trials of products evaluating efficacy and/or safety in support of a new indication or change in labeling to address unmet needs in rare diseases or conditions. Additionally, through the funding of collaborative, efficient, and/or innovative clinical trials, FDA expects to increase the number of approved treatments for rare diseases and exert a broad and positive impact on rare disease drug development.

Similar open opportunities